SpinePoint Receives FDA Clearance for Flex-Z Cervical Cage ORTHOFLASH Spine Built from 3D-printed porous titanium, Flex-Z is engineered to match cancelous bone stiffness in anterior cervical fusion. Mar 27, 2026
MARS Bioimaging Gains FDA Clearance for Portable CT Scanner ORTHOFLASH Robotics/Tech The scanner's photon-counting CT technology delivers high-resolution 3D X-ray images with clear material differentiation. Mar 26, 2026
Vy Spine Secures FDA Clearance for DiversiVy Facet Screw ORTHOFLASH Spine The DiversiVy Facet Screw System is intended to stabilize the spine as an aid to fusion by transfacet fixation. Mar 24, 2026
Turner Imaging Systems Expands Partnership to Serve EU Company Updates Competitive Landscape Under the new arrangement, Swissray Technologies will represent the SMART-C portable Mini C-Arm across all EU countries. Mar 24, 2026
Sectra Acquires Autonomous AI Company Oxipit ORTHOFLASH Robotics/Tech ChestLink is designed to automatically identify and clear high-confidence normal chest X-ray examinations from the radiologist's worklist. Mar 05, 2026
Arcuro Medical Expands SuperBall Platform ORTHOFLASH Trauma SuperBall-RC offers an all-suture, knotless solution for arthroscopic medial rotator cuff augmentation, with a mesh construct to minimize potential damage to tissue. Feb 17, 2026
Proprio Receives FDA Clearance For Picasso Feature Robotics/Tech The FDA clearance of the feature expands surgeon-controlled registration workflow within Proprio's Paradigm system. Jan 16, 2026
Treace Medical Secures Up to $175 Million in Debt Financing Investments The Numbers With the completion of this refinancing, the company now has total liquidity of approximately $165 million. Dec 18, 2025
IMPLANET Announces First JAZZ System Surgeries in China ORTHOFLASH Spine In July 2025, the JAZZ system obtained regulatory approval from the CFDA in China, paving the way for its commercialization there. Dec 17, 2025
Cerapedics Shares ASPIRE Study Results of PearlMatrix Bone Graft Orthobiologics ORTHOFLASH Study results demonstrated that PearlMatrix achieved superior clinical success and time-to-fusion at 24 months compared to local autograft. Dec 17, 2025